Autopsy report · NCT01663285

Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC)

“Low study participant enrollment.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 1 year 4 months before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 8 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

University of Michigan Rogel Cancer Center

Sponsor type

University, hospital or other

Conditions

Urothelial Cancer; Bladder Cancer

Interventions

Neoadjuvant Cisplatin and Gemcitabine

Participants

1

Sites

3

Countries

United States

Trials that died the same way

• A Preliminary Study Utilizing a Flexible Endoscope for Pelvic Culdoscopy
  “Low enrollment” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.